PLGF also inhibits differentiation of antigen-presenting dendritic cells and contributes to tumor growth, neovascularization, and lymphangiogenesis by increasing the recruitment of FLT1-expressing hematopoietic progenitor cells and monocytes [56,57]. The gene discussed is FLT1; the disease is neoplasm.